Needleman P, Kulkarni P S, Raz A
Science. 1977 Jan 28;195(4276):409-12. doi: 10.1126/science.831285.
Exogenous prostaglandin (PGE2) contracts bovine and human coronary arteries but its precursor, arachidonic acid, relaxes them. The endoperoxides PGH2 and PGH3 relax bovine coronary strips, but PGH1 produces contraction. The primary prostaglandins exert opposite effects to their own endoperoxide precursors, thus, PGE2 and PGE3 contract, and PGE1 relaxes the bovine coronary arteries. The paradoxical coronary dilation produced by the arachidonate or the PGH2 suggest that little if any coronary isomerase which converts endoperoxide into PGE2 exists, or that a novel, potent, PG-like substance is produced by the isolated coronary arteries. Although the coronaries do not possess thromboxane A2 synthetase activity, the vessels are profoundly contracted by exogenous thromboxane A2. Thromboxane A2 can be synthesized and released by circulating platelets when they are aggregated by endothelial injury or thrombin. Thus, coronary tone, and possible spasm, in ischemic myocardial zones may be influenced markedly by interplay between prostaglandins, endoperoxides, and thromboxane formed by platelets on the one hand, and endoperoxide products synthesized endogenously in the coronary arteries on the other.
外源性前列腺素(PGE2)可使牛和人的冠状动脉收缩,但其前体花生四烯酸却能使其舒张。内过氧化物PGH2和PGH3可使牛冠状动脉条舒张,但PGH1则引起收缩。初级前列腺素对其自身的内过氧化物前体产生相反的作用,因此,PGE2和PGE3可使牛冠状动脉收缩,而PGE1则使其舒张。花生四烯酸或PGH2所产生的矛盾性冠状动脉扩张表明,几乎不存在将内过氧化物转化为PGE2的冠状动脉异构酶,或者说分离出的冠状动脉产生了一种新型的、强效的、类前列腺素物质。尽管冠状动脉不具备血栓素A2合成酶活性,但外源性血栓素A2可使其强烈收缩。当循环中的血小板因内皮损伤或凝血酶而聚集时,可合成并释放血栓素A2。因此,一方面,缺血心肌区域的冠状动脉张力以及可能的痉挛,可能会受到前列腺素、内过氧化物和血小板形成的血栓素之间相互作用的显著影响;另一方面,也会受到冠状动脉内源性合成的内过氧化物产物的影响。